Research and Markets has announced the addition of the "Small Molecule Targeted Cancer Therapy Market by Type (Monoclonal Antibodies, Small Molecules, Small Molecule Drug Conjugates) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022" report to their offering.
Small Molecule Targeted Cancer Therapy is the medication that blocks the cancerous cells growth by destroying the targeted molecules that result in the growth of tumor and carcinogenesis. Conventional chemotherapies and cytotoxin medications destroy the division of cancerous cells by inhibiting the process of cell division.
Targeted Cancer therapy is considered to be more effective than the conventional methods and prevent normal cells from harmful radiations. Small Molecule Targeted Cancer Therapy has broad spectrum of application in multiple myeloma, melanoma, prostate cancer, lymphoma, breast cancer, and all other cancers.
Small Molecule Targeted Cancer Therapy has a targeted approach and minimal after side- effects; this results into increased rate of adoption of the therapy by the end users.
The substantial hurdle for the growth of the market is the rate of the approved chemical drugs that is declining every year due to stringent regulations. In addition, low awareness among end-users and high operational cost are also hampering the growth of the market.
For more information about this report visit http://www.researchandmarkets.com/research/vqrczx/small_molecule
View source version on businesswire.com: http://www.businesswire.com/news/home/20161007005652/en/Business Wire
Last updated on: 07/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.